## Note
nid: 1509300563305
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Lolnotacop::Drugs, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::*Basics, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::21_Cetuximab_Panitumumab, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::23_Rituximab, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::23_Rituximab::*Basics, #AK_Step1_v11::#OME_banner::Basic_Science::07_Immunology, #AK_Step1_v11::#Physeo::09_Pharm::09_Musculoskeletal::09_TNF-alpha_Inhibitors, #AK_Step1_v11::#Pixorize::02_Biochem::22_Onc_Drugs::02_Rituximab, #AK_Step1_v11::#Pixorize::02_Biochem::22_Onc_Drugs::03_Cetuximab,_Panitumumab, #AK_Step1_v11::#Pixorize::03_Pharm::11_Oncology::Cetuximab,_Panitumumab, #AK_Step1_v11::#Pixorize::03_Pharm::11_Oncology::Rituximab, #AK_Step1_v11::#Pixorize::03_Pharm::12_MSK::TNF_Inhibitors_(Infliximab,_Adalimumab._Certolizumab,_Golimumab), #AK_Step1_v11::#SketchyPharm::08_Antineoplastics::03_Kinase_Inhibitors_&_Monoclonal_Antibodies::02_Rituximab,_cetuximab,_bevacizumab,_alemtuzumab,_trastuzumab
markdown: false

### Text
<b>Chimeric monoclonal antibodies</b> can sometimes cause a(n)
<b>{{c1::serum sickness}}</b> within <u>{{c2::7-10}} days</u> of
administration

### Extra
<div>
  e.g. infliximab, cetuximab, rituximab, etc.
</div>
<div>
  type III HSR (immune complexes deposit in vessels -> activate
  complement -> neutrophils -> vasculitis and fibrinoid
  necrosis)
</div><img src="paste-24021752087016.jpg">

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="paste-34286723923971.jpg"><img src=
"paste-34359738368003.jpg"><img src=
"paste-34398393073667.jpg"><img src="paste-34540126994435.jpg">

### Sketchy
<img src="paste-390537081257985.jpg" class="resizer"><img src=
"paste-87d74ac95a67d78e1a0443bd770c17f44240fcf8.png" class=
"resizer"> <a href=
"https://dashboard.sketchy.com/study/medical/courses/medical-pharmacology/units/medical-pharmacology-antineoplastics/videos/medical-pharmacology-antineoplastics-kinase-inhibitors-and-monoclonal-antibodies-rituximab-cetuximab-bevacizumab-alemtuzumab-trastuzumab?utm_source=anki&utm_medium=partnership&utm_campaign=february_update&utm_content=medical">
Watch Rituximab, cetuximab, bevacizumab, alemtuzumab,
trastuzumab</a>

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/immunology?ref=anki"><img src=
  "_OME_AnkiFlashcards_Topic_5.png"></a>
</div>

### Additional Resources


### One by one

